Douglas E. Schaubel, PhD

Dr. Schaubel’s methodologic research interests mostly involve survival analysis and the analysis of recurrent event data. His more recent methodology has been at the intersection of causal inference and survival analysis and has focused on the evaluation of time-dependent treatments. Dr. Schaubel has also recently developed methods featuring landmark analysis and temporal process regression. Since 2005, Dr. Schaubel’s methodology has mostly been funded by an R01 grant, "Methods for the Analysis of Survival Processes Arising in End-Stage Renal Disease'' for which he is Principal Investigator.

Dr. Schaubel's collaborative work is mostly in the areas of end-stage renal disease and end-stage liver disease. Dr. Schaubel’s collaborations have served as the motivation for the majority of his methods research. Examples of specific areas of his interest include estimating the survival benefit of organ transplantation, and the evaluation of dialysis facilities and kidney transplant centers. Dr. Schaubel spent the first 17 years of his career at the University of Michigan Department of Biostatistics. His collaborators at Michigan included the UM Kidney Epidemiology and Cost Center (KECC); the UM Department of Surgery; and Arbor Research Collaborative for Health. Projects that he worked on included the Scientific Registry of Transplant Recipients contract; the United States Renal Data System (USRDS) contract; and the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Dr. Schaubel is a Fellow of the American Statistical Association. He received the Excellence in Research Award in 2015 from the University of Michigan School of Public Health. He is currently an Associate Editor for, Biometrics, Statistics in Medicine, Statistics in Biosciences and Lifetime Data Analysis. He is also a Statistical Reviewer for JAMA Network Open.


  • 2002 Ph.D. in Biostatistics, University of North Carolina at Chapel Hill
  • 1996 MSc in Biostatistics, McGill University
  • 1992 BMath in Actuarial Science, Statistics, University of Waterloo

Selected Publications

  • He K, Ashby VB, Schaubel DE: , Evaluating center-specific long-term outcomes through differences in mean survival time: Analysis of national kidney transplant data. Statistics in Medicine 38(11): 1957-1967, MAY 2019.
  • Zhan T, Schaubel DE: , Semiparametric temporal process regression of survival-out-of-hospital. Lifetime Data Analysis 25(2): 322-340, APR 2019.
  • Saran R, Robinson B, Abbott KC, Agodoa LYC, Bragg-Gresham J, Balkrishnan R, Bhave N, Dietrich X, Ding Z, Eggers PW, Gaipov A, Gillen D, Gipson D, Gu H, Guro P, Haggerty D, Han Y, He K, Herman W, Heung M, Hirth RA, Hsiung JT, Hutton D, Inoue A, Jacobsen SJ, Jin Y, Kalantar-Zadeh K, Kapke A, Kleine CE, Kovesdy CP, Krueter W, Kurtz V, Li Y, Liu S, Marroquin MV, McCullough K, Molnar MZ, Modi Z, Montez-Rath M, Moradi H, Morgenstern H, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, O'Hare AM, Obi Y, Park C, Pearson J, Pisoni R, Potukuchi PK, Repeck K, Rhee CM, Schaubel DE, Schrager J, Selewski DT, Shamraj R, Shaw SF, Shi JM, Shieu M, Sim JJ, Soohoo M, Steffick D, Streja E, Sumida K, Kurella Tamura M, Tilea A, Turf M, Wang D, Weng W, Woodside KJ, Wyncott A, Xiang J, Xin X, Yin M, You AS, Zhang X, Zhou H, Shahinian V: , US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. American Journal of Kidney Diseases 73(3 Suppl 1 ): A7-A8, MAR 2019.
  • Modi ZJ, Lu Y, Ji N, Kapke A, Selewski DT, Dietrich X, Abbott K, Nallamothu BK, Schaubel DE, Saran R, Gipson DS: , Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal Disease: An Analysis of the US Renal Data System. JAMA Cardiology MAR 2019 Notes: doi: 10.1001/jamacardio.2019.0375. [Epub ahead of print]
  • Zhong Y, Schaubel DE, Kalbfleisch JD, Ashby VB, Rao PS, Sung RS: , Reevaluation of the Kidney Donor Risk Index (KDRI). Transplantation NOV 2018 Notes: doi:10.1097/TP.0000000000002498. [Epub ahead of print]
  • Siontis, KC, Zhang, XS, Eckard, A, Bhave, N, Schaubel, DE, He, K, Tilea, A, Stack, AG, Balkrishnan, R, Yao, XX, Noseworthy, PA, Shah, ND, Saran, R, Nallamothu, BK: , Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States. Circulation 138(15): 1519-1529, OCT 2018.
  • Welling TH, Eddinger K, Carrier K, Zhu D, Kleaveland T, Moore DE, Schaubel DE, Abt PL: , Multicenter Study of Staging and Therapeutic Predictors of Hepatocellular Carcinoma Recurrence Following Transplantation. Liver Transplantation 24(9): 1233-1242, SEP 2018.
  • Woodside, KJ, Bell, S, Mukhopadhyay, P, Repeck, KJ, Robinson, IT, Eckard, AR, Dasmunshi, S, Plattner, BW, Pearson, J, Schaubel, DE, Pisoni, RL, Saran, R: , Erratum Regarding "Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: A National Study" (vol 71, pg 793, 2018). American Journal of Kidney Diseases 72(2): 314, AUG 2018.
  • Kim, S, Schaubel, DE, McCullough, KP: , A C-index for recurrent event data: Application to hospitalizations among dialysis patients. Biometrics 74(2): 734-743, JUN 2018.
  • Woodside KJ, Bell S, Mukhopadhyay P, Repeck KJ, Robinson IT, Eckard AR, Dasmunshi S, Plattner BW, Pearson J, Schaubel DE, Pisoni RL, Saran R: ,Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: A National Study. American Journal of Kidney Diseases 71(6): 793-801, JUN 2018.